News
AIDX
1.915
+0.26%
0.005
20/20 BioLabs Says Its OneTest For Cancer Is Now Available Through Evexia Diagnostics Platform
Benzinga · 2d ago
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
Barchart · 2d ago
20/20 BioLabs files to sell 10.1M shares of common stock for holders
TipRanks · 2d ago
Weekly Report: what happened at AIDX last week (0330-0403)?
Weekly Report · 3d ago
20/20 Biolabs, Inc. GAAP EPS of -$0.76, revenue of $2M
Seeking Alpha · 04/01 13:00
20/20 Biolabs FY EPS $(0.76) Up From $(1.16) YoY, Sales $2.045M Up From $1.752M YoY
Benzinga · 03/31 21:00
Press Release: 20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
Dow Jones · 03/31 20:57
Press Release: 20/20 BioLabs Reports Full Year -2-
Dow Jones · 03/31 20:57
Press Release: 20/20 BioLabs Reports Full Year -3-
Dow Jones · 03/31 20:57
Weekly Report: what happened at AIDX last week (0323-0327)?
Weekly Report · 03/30 10:48
20/20 BioLabs announces grants for Maryland fire departments to procure OneTest
TipRanks · 03/27 12:57
20/20 BioLabs Secures $520K MDH Grant To Deploy OneTest MCED Blood Test Across Maryland Fire Departments
Benzinga · 03/27 12:34
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test
Barchart · 03/27 07:31
20/20 BioLabs Secure U.S. License For Advanced CKD Prediction Technology
NASDAQ · 03/25 12:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 03/24 21:05
What's Going On With 20/20 Biolabs Stock?
Benzinga · 03/24 15:07
20/20 BioLabs enters exclusive technology license, access agreement with Rokit
TipRanks · 03/24 12:46
20/20 BioLabs Partners With ROKIT To Add AI-Driven Kidney Disease Risk And Biomarker Insights To Longevity Platform
Benzinga · 03/24 12:35
20/20 BIOLABS ANNOUNCES EXCLUSIVE U.S. LICENSE AGREEMENT WITH ROKIT HEALTHCARE TO INTEGRATE ADVANCED CKD PREDICTION TECHNOLOGY INTO ITS LONGEVITY TEST PROGRAM
Reuters · 03/24 12:31
20/20 BIOLABS INC: UNDER AGREEMENT, ROKIT AGREED TO REIMBURSE 20/20 FOR ONE-THIRD OF MUTUALLY AGREED SALES AND MARKETING EXPENSES
Reuters · 03/24 12:31
More
Webull provides a variety of real-time AIDX stock news. You can receive the latest news about 20/20 Biolabs Inc through multiple platforms. This information may help you make smarter investment decisions.
About AIDX
20/20 Biolabs Inc, formerly 20/20 GeneSystems, Inc., is a digital diagnostics company, which is engaged in developing and commercializing clinical laboratory tests and associated software that is powered by machine learning and real-word data to improve diagnostic accuracy and clinical usefulness. The Company offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.